Tag: FDA
Expanded FDA Authority Is Tackling Security In The Medical Device Industry
The medical device industry is undergoing significant changes as the US Food and Drug Administration (FDA) expands its authority to include cybersecurity requirements. The...
FDA’s Medical Interference, Time for ESG Antitrust Action and other commentary
By Editorial Board, NY Post
Libertarian: FDA’s Medical Interference
“Secreted within the 2023 omnibus appropriations bill,” notes Joel Zinberg in The Wall Street Journal, “is a 19-line...
Lupin Settles Glumetza Case For $150M
Lupin will pay US$150 million to resolve antitrust litigation over its alleged role in a scheme to delay generic versions of the blockbuster diabetes...
US: FDA names drugmakers potentially acting to delay cheap generics
The US Food and Drug Administration (FDA) on Thursday, May 17, listed drugmakers, including Celgene, Johnson & Johnson, Gilead Sciences and Novartis, which the...
Refusal to Deal Under FDA Imposed Risk Evaluation and Mitigation Strategies...
This article is part of a Chronicle. See more from this Chronicle
Robert Maness, Brian Segers, Apr 29, 2014
The Federal Trade Commission, as part of...
Regulation of Information and Advertising
Paul Rubin, Apr 24, 2008
A version of this article was originally prepared for the Encyclopedia of Law and Economics (Edward Elgar, 2nd ed. 2008/2009)....
